Company intelligence / Profile preview

Gelscom

Ownership: Private
Development stage: Other

Overview

Gelscom develops and manufactures CE-marked minimally invasive hydrogel-based medical devices for the treatment of herniated discs. Their flagship product Discogel has demonstrated immediate pain reduction in up to 80% of patients with a nearly 90% success rate for treating cervical, thoracic, and lumbar disc herniation. The company also produces Sclerogel for similar indications.

Therapeutic areas: Neurology
Modalities: DeviceHydrogel-based drug delivery therapy
Industry: Therapeutic Medical Devices

Partnerships

Notable distribution partnerships with companies such as ab medica and Medcin Pharma.

Beyond the preview

Go deeper on Gelscom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gelscom.

Explore the full profile